4.5 Article

Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty The FOXTROT Randomized Clinical Trial

Jeffrey I. Weitz et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Chemistry, Medicinal

Recent advances in the discovery and development of factor XI/XIa inhibitors

Rami A. Al-Horani et al.

MEDICINAL RESEARCH REVIEWS (2018)

Article Pharmacology & Pharmacy

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

Stephen P. H. Alexander et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Article Medicine, General & Internal

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Harry R. Bueller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Education, Scientific Disciplines

Future prospects for contact factors as therapeutic targets

David Gailani

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)

Review Hematology

Structure and function of factor XI

Jonas Emsley et al.

Editorial Material Cardiac & Cardiovascular Systems

Venous Thromboembolism and Atherothrombosis An Integrated Approach

Gregory Piazza et al.

CIRCULATION (2010)

Article Hematology

Structural and functional features of factor XI

D. Gailani et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)

Article Hematology

Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice

X. Wang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)